{"id":52374,"date":"2022-12-28T02:02:18","date_gmt":"2022-12-28T01:02:18","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/jack-nathan-health-announces-voting-results-from-annual-and-special-shareholders-meeting\/"},"modified":"2022-12-28T02:02:18","modified_gmt":"2022-12-28T01:02:18","slug":"jack-nathan-health-announces-voting-results-from-annual-and-special-shareholders-meeting","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/jack-nathan-health-announces-voting-results-from-annual-and-special-shareholders-meeting\/","title":{"rendered":"Jack Nathan Health Announces Voting Results from Annual and Special Shareholders\u2019 Meeting"},"content":{"rendered":"
\n

TORONTO–(BUSINESS WIRE)–Jack Nathan Medical Corp. (<\/b>TSXV: \u201cJNH\u201d; OTCQB: \u201cJNHMF\u201d) <\/b>(the \u201cCompany<\/b>\u201d) is pleased to announce that all of the matters presented for approval at its annual and special meeting of shareholders of the Company (the \u201cAGM<\/b>\u201d) held on Friday, December 23, 2022 were approved. The AGM was originally called for December 2, 2022, but was adjourned until December 23, 2022 (see the Company\u2019s press release dated December 2, 2022).\n<\/p>\n

<\/a><\/p>\n

\nAll of the nominees listed in the Company\u2019s management information circular dated November 2, 2022 forwarded to shareholders in respect of the AGM (the \u201cCircular<\/b>\u201d) were elected at the AGM as directors of the Company, to hold office until the close of the next annual meeting of shareholders of the Company or until their successors are duly elected or appointed. The detailed results of the vote at the AGM on the election of directors are set out below:\n<\/p>\n\n\n\n\n\n\n\n\n
<\/td>\n\n

\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nName<\/b>\n<\/p>\n<\/td>\n

\n

\n% Votes For\n<\/p>\n<\/td>\n

\n

\n% Votes Withheld\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nMichael Marchelleta\n<\/p>\n<\/td>\n

\n

\n97.8%\n<\/p>\n<\/td>\n

\n

\n2.2%\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nNeil J. Labatte\n<\/p>\n<\/td>\n

\n

\n97.8%\n<\/p>\n<\/td>\n

\n

\n2.2%\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nAnthony DeCristofaro\n<\/p>\n<\/td>\n

\n

\n97.8%\n<\/p>\n<\/td>\n

\n

\n2.2%\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nBlake D. Lyon\n<\/p>\n<\/td>\n

\n

\n97.8%\n<\/p>\n<\/td>\n

\n

\n2.2%\n<\/p>\n<\/td>\n<\/tr>\n

\n

\nGlenn Copeland\n<\/p>\n<\/td>\n

\n

\n98.0%\n<\/p>\n<\/td>\n

\n

\n2.0%\n<\/p>\n<\/td>\n<\/tr>\n<\/table>\n

\nShareholders of the Company also passed at the AGM the following resolutions:\n<\/p>\n

\n(a) the resolution reappointing MNP LLP as auditors of the Company to hold office until the close of the next annual meeting of shareholders of the Company, and authorizing the board of directors of the Company to fix the auditors\u2019 remuneration and the terms of their engagement (99.2% of the votes cast at the AGM were in favour of the resolution and 0.8% of the votes cast at the AGM were withheld from voting on the resolution);\n<\/p>\n

\n(b) the resolution (i) approving a certain amendment to the Company’s Omnibus Equity Incentive Plan (the \u201cPlan<\/b>\u201d), as such amendment is described in the Circular, and (ii) approving the Plan as amended by such amendment, as required pursuant to the rules of the TSX Venture Exchange (94.6% of the votes cast at the AGM were in favour of the resolution and 5.4% of the votes cast at the AGM were against the resolution);\n<\/p>\n

\n(c) the resolution approving the grant of certain restricted stock units of the Company (\u201cRSUs<\/b>\u201d) pursuant to the Plan, as described in the Circular and below (94.5% of the votes cast at the AGM were in favour of the resolution (all such votes were \u201cdisinterested\u201d as per the rules of the TSX Venture Exchange) and 5.5% of the votes cast at the AGM were against the resolution); and\n<\/p>\n

\n(d) the resolution confirming the making of a by-law of the Company providing advance notice requirements for the nomination of directors of the Company, as described in the Circular (98.0% of the votes cast at the AGM were in favour of the resolution and 2.0% of the votes cast at the AGM were against the resolution).\n<\/p>\n

\nAs referred to above, at the AGM shareholders approved the grant by the Company to the Company\u2019s Chief Executive Officer as of the \u201cdate of grant\u201d (such date of grant being the next business day following such shareholders\u2019 approval, which business day is today) the following RSUs pursuant to the terms of the Plan: (i) 2,250,000 RSUs, such RSUs vesting 12 months from such date of grant and subject to the terms and conditions of the Plan; and (ii) 2,500,000 RSUs, with the vesting of such RSUs tied to certain performance achievements over the next three years from the grant date.\n<\/p>\n

\nSuch approval also included shareholder approval for the grant by the Company to the Company\u2019s Chief Operating Officer as of the \u201cdate of grant\u201d (such date of grant being the next business day following such shareholder approval, which business day is today) a total of 750,000 RSUs pursuant to the terms of the Plan, with the vesting of 250,000 of the RSUs to be the same as the vesting condition set out in item (i) above, and the vesting of 500,000 of the RSUs to be the same as the vesting condition set out in item (ii) above.\n<\/p>\n

\nAbout Jack Nathan Medical Corp.<\/b>\n<\/p>\n

\nJack Nathan Medical Corp., operating as Jack Nathan Health\u00ae<\/sup>, is one of Canada\u2019s largest healthcare networks. Jack Nathan Health\u00ae is an innovative healthcare company that is improving access for millions of patients by co-locating physician and ancillary medical services conveniently located inside Walmart\u00ae<\/sup> stores.\n<\/p>\n

\nJack Nathan Health\u00ae<\/sup> provides an exceptional level of patient care, made possible through patient-centric physicians, a variety of medical services, technology, and programs, designed to put patients first. Our mission is to provide everyone access to the finest quality retail medical centres, with both in-clinic physicians and digital telemedicine, so you and your loved ones can \u201cLive Your Best Life\u201d.\n<\/p>\n

\nJack Nathan Health\u00ae<\/sup> was established in 2006 and continues to expand its international footprint, delivering exceptional, state-of-the-art, turn-key medical centres. In Canada, the Company has 76 clinics in Walmart locations in British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, and Quebec. 18 clinics, 4 Rehab and 5 MedSpa are corporate owned and operated. In Mexico, the Company has 114 corporate owned and operated clinics in Walmart locations.\n<\/p>\n

\nFor more information, visit www.jacknathanhealth.com<\/a> or www.sedar.com<\/a>.\n<\/p>\n

\nNeither the TSX Venture Exchange nor its Regulation Services Provider (as defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.<\/i><\/b>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nJack Nathan Medical Corp., Spence Walker, CFO, spence.walker@jacknathanhealth.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

TORONTO–(BUSINESS WIRE)–Jack Nathan Medical Corp. (TSXV: \u201cJNH\u201d; OTCQB: \u201cJNHMF\u201d) (the \u201cCompany\u201d) is pleased to announce that all of the matters presented for approval at its annual and special meeting of shareholders of the Company (the \u201cAGM\u201d) held on Friday, December 23, 2022 were approved. The AGM was originally called for December 2, 2022, but was … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-52374","6":"format-standard","7":"category-industry"},"yoast_head":"\nJack Nathan Health Announces Voting Results from Annual and Special Shareholders\u2019 Meeting - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/jack-nathan-health-announces-voting-results-from-annual-and-special-shareholders-meeting\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Jack Nathan Health Announces Voting Results from Annual and Special Shareholders\u2019 Meeting - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"TORONTO–(BUSINESS WIRE)–Jack Nathan Medical Corp. (TSXV: \u201cJNH\u201d; OTCQB: \u201cJNHMF\u201d) (the \u201cCompany\u201d) is pleased to announce that all of the matters presented for approval at its annual and special meeting of shareholders of the Company (the \u201cAGM\u201d) held on Friday, December 23, 2022 were approved. The AGM was originally called for December 2, 2022, but was ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/jack-nathan-health-announces-voting-results-from-annual-and-special-shareholders-meeting\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-12-28T01:02:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221227005253\/en\/1583036\/21\/Jack_Nathan_Health_Official_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/jack-nathan-health-announces-voting-results-from-annual-and-special-shareholders-meeting\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/jack-nathan-health-announces-voting-results-from-annual-and-special-shareholders-meeting\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Jack Nathan Health Announces Voting Results from Annual and Special Shareholders\u2019 Meeting\",\"datePublished\":\"2022-12-28T01:02:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/jack-nathan-health-announces-voting-results-from-annual-and-special-shareholders-meeting\\\/\"},\"wordCount\":865,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/jack-nathan-health-announces-voting-results-from-annual-and-special-shareholders-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221227005253\\\/en\\\/1583036\\\/21\\\/Jack_Nathan_Health_Official_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/jack-nathan-health-announces-voting-results-from-annual-and-special-shareholders-meeting\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/jack-nathan-health-announces-voting-results-from-annual-and-special-shareholders-meeting\\\/\",\"name\":\"Jack Nathan Health Announces Voting Results from Annual and Special Shareholders\u2019 Meeting - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/jack-nathan-health-announces-voting-results-from-annual-and-special-shareholders-meeting\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/jack-nathan-health-announces-voting-results-from-annual-and-special-shareholders-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221227005253\\\/en\\\/1583036\\\/21\\\/Jack_Nathan_Health_Official_Logo.jpg\",\"datePublished\":\"2022-12-28T01:02:18+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/jack-nathan-health-announces-voting-results-from-annual-and-special-shareholders-meeting\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/jack-nathan-health-announces-voting-results-from-annual-and-special-shareholders-meeting\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/jack-nathan-health-announces-voting-results-from-annual-and-special-shareholders-meeting\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221227005253\\\/en\\\/1583036\\\/21\\\/Jack_Nathan_Health_Official_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221227005253\\\/en\\\/1583036\\\/21\\\/Jack_Nathan_Health_Official_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/jack-nathan-health-announces-voting-results-from-annual-and-special-shareholders-meeting\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Jack Nathan Health Announces Voting Results from Annual and Special Shareholders\u2019 Meeting\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Jack Nathan Health Announces Voting Results from Annual and Special Shareholders\u2019 Meeting - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/jack-nathan-health-announces-voting-results-from-annual-and-special-shareholders-meeting\/","og_locale":"en_US","og_type":"article","og_title":"Jack Nathan Health Announces Voting Results from Annual and Special Shareholders\u2019 Meeting - Pharma Trend","og_description":"TORONTO–(BUSINESS WIRE)–Jack Nathan Medical Corp. (TSXV: \u201cJNH\u201d; OTCQB: \u201cJNHMF\u201d) (the \u201cCompany\u201d) is pleased to announce that all of the matters presented for approval at its annual and special meeting of shareholders of the Company (the \u201cAGM\u201d) held on Friday, December 23, 2022 were approved. The AGM was originally called for December 2, 2022, but was ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/jack-nathan-health-announces-voting-results-from-annual-and-special-shareholders-meeting\/","og_site_name":"Pharma Trend","article_published_time":"2022-12-28T01:02:18+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221227005253\/en\/1583036\/21\/Jack_Nathan_Health_Official_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/jack-nathan-health-announces-voting-results-from-annual-and-special-shareholders-meeting\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/jack-nathan-health-announces-voting-results-from-annual-and-special-shareholders-meeting\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Jack Nathan Health Announces Voting Results from Annual and Special Shareholders\u2019 Meeting","datePublished":"2022-12-28T01:02:18+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/jack-nathan-health-announces-voting-results-from-annual-and-special-shareholders-meeting\/"},"wordCount":865,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/jack-nathan-health-announces-voting-results-from-annual-and-special-shareholders-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221227005253\/en\/1583036\/21\/Jack_Nathan_Health_Official_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/jack-nathan-health-announces-voting-results-from-annual-and-special-shareholders-meeting\/","url":"https:\/\/pharma-trend.com\/en\/jack-nathan-health-announces-voting-results-from-annual-and-special-shareholders-meeting\/","name":"Jack Nathan Health Announces Voting Results from Annual and Special Shareholders\u2019 Meeting - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/jack-nathan-health-announces-voting-results-from-annual-and-special-shareholders-meeting\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/jack-nathan-health-announces-voting-results-from-annual-and-special-shareholders-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221227005253\/en\/1583036\/21\/Jack_Nathan_Health_Official_Logo.jpg","datePublished":"2022-12-28T01:02:18+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/jack-nathan-health-announces-voting-results-from-annual-and-special-shareholders-meeting\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/jack-nathan-health-announces-voting-results-from-annual-and-special-shareholders-meeting\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/jack-nathan-health-announces-voting-results-from-annual-and-special-shareholders-meeting\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221227005253\/en\/1583036\/21\/Jack_Nathan_Health_Official_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221227005253\/en\/1583036\/21\/Jack_Nathan_Health_Official_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/jack-nathan-health-announces-voting-results-from-annual-and-special-shareholders-meeting\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Jack Nathan Health Announces Voting Results from Annual and Special Shareholders\u2019 Meeting"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52374","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=52374"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52374\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=52374"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=52374"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=52374"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}